|
|
Volumn 2, Issue 2, 2001, Pages 89-91
|
|
Experience of nevirapine use in a London cohort of HIV-infected pregnant women
a,b
|
|
Author keywords
HAART; HIV; Pregnancy
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CD4 ANTIGEN;
DIDANOSINE;
LAMIVUDINE;
NEVIRAPINE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
STAVUDINE;
ZIDOVUDINE;
ADULT;
AGE;
ARTICLE;
CLINICAL ARTICLE;
COHORT ANALYSIS;
CONTROLLED STUDY;
DRUG TOLERABILITY;
DRUG USE;
EXPERIENCE;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HELPER CELL;
HEPATITIS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RESPONSE;
LABORATORY TEST;
LYMPHOCYTE COUNT;
MEDICAL RECORD;
NEGRO;
PREGNANCY;
PREGNANCY COMPLICATION;
PREMATURE LABOR;
PRIORITY JOURNAL;
RASH;
SECOND TRIMESTER PREGNANCY;
SIDE EFFECT;
STATISTICAL ANALYSIS;
THIRD TRIMESTER PREGNANCY;
UNITED KINGDOM;
VIREMIA;
VIROLOGY;
VIRUS DETECTION;
VIRUS LOAD;
ADULT;
ANTI-HIV AGENTS;
CD4 LYMPHOCYTE COUNT;
COHORT STUDIES;
DISEASE TRANSMISSION, VERTICAL;
FEMALE;
HIV INFECTIONS;
HIV-1;
HUMANS;
NEVIRAPINE;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
PREGNANCY OUTCOME;
VIRAL LOAD;
VIREMIA;
|
|
EID: 0035203126
PISSN: 14642662
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1468-1293.2001.00059.x Document Type: Article |
|
Times cited : (15)
|
|
References (10)
|
